The International Index of Erectile Function (IIEF) is considered the “gold standard” tool for assessing erectile dysfunction (ED). While categories of ED severity have been suggested based on the IIEF, there is currently no standard way to evaluate minimal clinically important difference (MCID) or define an ED treatment responder. As a result, there is no objective way to determine whether ED treatment is effective.
The present study is a meta-analysis focusing on the safety and efficacy of ospemifene to treat dyspareunia associated with postmenopausal vulvar and vaginal atrophy (VVA).
Insufficient privacy during sex is one of the most common issues that can interfere with a couple’s intimacy and sexual function. For example, lack of privacy may be an issue for young people who live with their parents or with roommates. It can also affect parents who have children at home. Assessments of sexual function do not usually include items on sexual privacy. This study examined the issue in a large sample of men who were consulting for sexual dysfunction.
Some young men have weaker masturbatory erections with no sexual intercourse (WME-NS). Many professionals believe ED in younger men is psychogenic and do not investigate other risk factors. This study aimed to determine whether underlying risk factors exist in men with WME-NS and whether such risk factors are similar to those of men with identified ED.
The aim of this study was to examine the acute (curative) effect of tadalafil dosing on Met-S associated increased signaling of RhoA/ROCK in the bladder.
Women’s perceptions of PE have not been widely researched. Recent studies have had mixed results. Examining these issues more closely could help clinicians better understand the physical, psychological, and interpersonal aspects of PE for couples.